Cargando…
P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431191/ http://dx.doi.org/10.1097/01.HS9.0000971192.89168.b4 |
_version_ | 1785091142991216640 |
---|---|
author | Yu, Wenyan Geng, Mei Hao, Jie Yan, Zeying MI, Jian-Qing |
author_facet | Yu, Wenyan Geng, Mei Hao, Jie Yan, Zeying MI, Jian-Qing |
author_sort | Yu, Wenyan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104311912023-08-17 P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA Yu, Wenyan Geng, Mei Hao, Jie Yan, Zeying MI, Jian-Qing Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431191/ http://dx.doi.org/10.1097/01.HS9.0000971192.89168.b4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Yu, Wenyan Geng, Mei Hao, Jie Yan, Zeying MI, Jian-Qing P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA |
title | P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA |
title_full | P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA |
title_fullStr | P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA |
title_full_unstemmed | P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA |
title_short | P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA |
title_sort | p1074: prognosis analysis and a new risk model for relapsed and refractory hodgkin lymphoma patients treated by anti-pd-1: a real-world multicenter retrospective study of patients in china |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431191/ http://dx.doi.org/10.1097/01.HS9.0000971192.89168.b4 |
work_keys_str_mv | AT yuwenyan p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina AT gengmei p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina AT haojie p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina AT yanzeying p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina AT mijianqing p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina |